BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 19167086)

  • 1. The association of cutaneous and iris nevi with uveal melanoma: a meta-analysis.
    Weis E; Shah CP; Lajous M; Shields JA; Shields CL
    Ophthalmology; 2009 Mar; 116(3):536-543.e2. PubMed ID: 19167086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Connection between uveal melanoma and dysplastic naevus syndrome].
    Hammer H; Tóth-Molnár E; Oláh J; Dobozy A
    Magy Onkol; 2005; 49(1):15-8. PubMed ID: 15902328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic study of familial uveal melanoma: association of uveal and cutaneous melanoma with cutaneous and ocular nevi.
    Smith JH; Padnick-Silver L; Newlin A; Rhodes K; Rubinstein WS
    Ophthalmology; 2007 Apr; 114(4):774-9. PubMed ID: 17207529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cutaneous dysplastic naevi in uveal melanoma patients: markers for prognosis?
    Tóth-Molnár E; Hammer H; Oláh J
    Melanoma Res; 2000 Feb; 10(1):36-9. PubMed ID: 10711638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dysplastic nevi in association with multiple primary melanoma.
    Titus-Ernstoff L; Duray PH; Ernstoff MS; Barnhill RL; Horn PL; Kirkwood JM
    Cancer Res; 1988 Feb; 48(4):1016-8. PubMed ID: 3338073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ocular melanoma: epidemiology, clinical presentation and relationship with dysplastic nevi.
    Richtig E; Langmann G; Müllner K; Smolle J
    Ophthalmologica; 2004; 218(2):111-4. PubMed ID: 15004500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Meta-analysis of risk factors for cutaneous melanoma: I. Common and atypical naevi.
    Gandini S; Sera F; Cattaruzza MS; Pasquini P; Abeni D; Boyle P; Melchi CF
    Eur J Cancer; 2005 Jan; 41(1):28-44. PubMed ID: 15617989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Demographic study of clinically atypical (dysplastic) nevi in patients with melanoma and comparison subjects.
    Nordlund JJ; Kirkwood J; Forget BM; Scheibner A; Albert DM; Lerner E; Milton GW
    Cancer Res; 1985 Apr; 45(4):1855-61. PubMed ID: 3978645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Positive interaction between light iris color and ultraviolet radiation in relation to the risk of uveal melanoma: a case-control study.
    Schmidt-Pokrzywniak A; Jöckel KH; Bornfeld N; Sauerwein W; Stang A
    Ophthalmology; 2009 Feb; 116(2):340-8. PubMed ID: 19091418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dysplastic nevi as risk markers of sporadic (nonfamilial) melanoma. A case-control study.
    Halpern AC; Guerry D; Elder DE; Clark WH; Synnestvedt M; Norman S; Ayerle R
    Arch Dermatol; 1991 Jul; 127(7):995-9. PubMed ID: 2064418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence of new and changed nevi and melanomas detected using baseline images and dermoscopy in patients at high risk for melanoma.
    Banky JP; Kelly JW; English DR; Yeatman JM; Dowling JP
    Arch Dermatol; 2005 Aug; 141(8):998-1006. PubMed ID: 16103329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Minichromosome maintenance protein expression in benign nevi, dysplastic nevi, melanoma, and cutaneous melanoma metastases.
    Boyd AS; Shakhtour B; Shyr Y
    J Am Acad Dermatol; 2008 May; 58(5):750-4. PubMed ID: 18249467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dysplastic nevi in relation to superficial spreading melanoma.
    Titus-Ernstoff L; Barnhill RL; Duray PH; Ernstoff MS; Kirkwood JM
    Cancer Epidemiol Biomarkers Prev; 1993; 2(2):99-101. PubMed ID: 8467253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of total body photography on biopsy rate in patients from a pigmented lesion clinic.
    Risser J; Pressley Z; Veledar E; Washington C; Chen SC
    J Am Acad Dermatol; 2007 Sep; 57(3):428-34. PubMed ID: 17624623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Are atypical nevi a risk factor for uveal melanoma? A case-control study.
    van Hees CL; de Boer A; Jager MJ; Bleeker JC; Kakebeeke HM; Crijns MB; Vandenbroucke JP; Bergman W
    J Invest Dermatol; 1994 Aug; 103(2):202-5. PubMed ID: 8040610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary cutaneous malignant melanoma and its precursor lesions: diagnostic and therapeutic overview.
    Kanzler MH; Mraz-Gernhard S
    J Am Acad Dermatol; 2001 Aug; 45(2):260-76. PubMed ID: 11464189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dysplastic naevi with moderate to severe histological dysplasia: a risk factor for melanoma.
    Shors AR; Kim S; White E; Argenyi Z; Barnhill RL; Duray P; Erickson L; Guitart J; Horenstein MG; Lowe L; Messina J; Rabkin MS; Schmidt B; Shea CR; Trotter MJ; Piepkorn MW
    Br J Dermatol; 2006 Nov; 155(5):988-93. PubMed ID: 17034530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for melanoma incidence in prospective follow-up. The importance of atypical (dysplastic) nevi.
    Schneider JS; Moore DH; Sagebiel RW
    Arch Dermatol; 1994 Aug; 130(8):1002-7. PubMed ID: 8053695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Grading of atypia in nevi: correlation with melanoma risk.
    Arumi-Uria M; McNutt NS; Finnerty B
    Mod Pathol; 2003 Aug; 16(8):764-71. PubMed ID: 12920220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between posterior uveal melanoma and iris freckles, iris naevi, and choroidal naevi.
    Harbour JW; Brantley MA; Hollingsworth H; Gordon M
    Br J Ophthalmol; 2004 Jan; 88(1):36-8. PubMed ID: 14693769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.